Better Access Australia says the inquiry into approval processes for new drugs and novel medical technologies must use public hearings to question companies about the potential impact of the move to strip confidentiality protections for PBAC submission sponsors. …
Committee needs to focus on impact of confidentiality change
April 23, 2021 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Health department makes a major change inside critical division
May 17, 2024 - - Latest News -
Baxter launches the mission and logo of new kidney care company
May 16, 2024 - - Latest News -
NZ Prime Minister says, 'We are recognising that we have a problem'
May 16, 2024 - - Latest News -
Generic and biosimilar sector welcomes the Government's 'cost of living' Budget
May 16, 2024 - - Latest News -
Budget provides minimal support for projects to build APS capability
May 16, 2024 - - Latest News -
Mark Butler establishes a place in history by ruling out new PBS savings measures
May 16, 2024 - - Latest News -
The 2024-25 Budget Review Podcast
May 15, 2024 - - Podcast